We evaluated the efficacy and safety of combined therapy with an alpha-blocker (tamsulosin 0.2 mg) and low-dose anti-cholinergics (propiverine HCl 10 mg) in patients with benign prostatic hyperplasia (BPH) accompanied by overactive bladder (OAB) symptoms. Materials and Methods: This prospective study enrolled 119 male patients with lower urinary tract symptoms (LUTS) with prostate volume of 20 ml or greater, International Prostate Symptom Score (IPSS) of more than 8, and OAB symptoms from May 2007 to April 2008. Patients with post-void residual volume (PVR) over 100 ml were excluded. Among these patients, 74 patients were treated with tamsulosin 0.2 mg plus propiverine HCl 10 mg (group A) and 45 patients were treated with tamsulosin 0.2 mg only (group B). The clinical parameters, including IPSS, quality of life (QoL) score, uroflowmetry, and PVR were re-evaluated after 3 months. Results: A total of 115 patients, including 70 in group A and 45 in group B, completed the study. IPSS, QoL score, voided volume, maximum flow rate (Qmax), and PVR showed significant improvement after 3 months of treatment (p＜0.05). Baseline characteristics between the 2 groups were not significantly different for any parameter (p＞0.05). Changes in the QoL score were −1.9±1.1 and −1.5±0.9 for group A and group B, respectively (p=0.043). Changes in all other parameters were not significantly different between the 2 groups (p＞0.05). Conclusions: For those patients with LUTS due to BPH and concomitant OAB, combination therapy with an alpha-blocker (tamsulosin 0.2 mg) and low-dose anti-cholinergics (propiverine HCl 10 mg) may be a reasonable and effective therapeutic option as an initial therapy. (Korean J Urol 2009;50:1078-1082) 서 론 전립선비대증으로 인한 방광출구폐색이 존재하는 경우 50-75%에서는 과민성방광을 동반하며, 전립선비대증을 치 료한 후에도 과민성방광이 약 38%에서는 지속되는 것으로 알려져 있다 [1-3]. 또한 연령이 높거나 하부요로폐색이 심 할수록 전립선비대증으로 인한 과민성방광의 발생률도 증 가하는 것으로 보고되고 있다 [4,5]. 과민성방광으로 인한 저장증상은 배뇨증상보다 더 큰 고통을 줄 수 있으며 [6], 과민성방광을 동반한 전립선비대증의 경우 알파차단제 단 독치료만으로는 충분한 치료효과를 얻기 어렵다. 이러한 이유로 전립선비대증에 동반된 과민성방광 환자에서 항콜 린제 사용이 시도되고 있다. 이전의 많은 연구에서 알파차 단제와 항콜린제 병합요법의 효과 및 안전성은 확인되었으 나 [7-13], 아직까지도 항콜린제에 의한 잔뇨의 증가 및 요 Kang Il Seo, et al：Combination of α-Blocker and Low Dose Propiverine in BPH/OAB 1079

